Bank Albilad (TADAWUL:1140)
25.88
-0.14 (-0.54%)
Aug 7, 2025, 3:19 PM AST
Blueprint Medicines Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 5,717 | 8,727 | 6,869 | 9,024 | 3,470 | 2,907 | Upgrade |
Investment Securities | 27,613 | 23,910 | 21,018 | 19,710 | 16,109 | 13,777 | Upgrade |
Trading Asset Securities | 1,024 | 1,147 | 1,087 | 929.16 | 683.6 | 806.67 | Upgrade |
Total Investments | 28,637 | 25,057 | 22,105 | 20,639 | 16,792 | 14,584 | Upgrade |
Gross Loans | 118,057 | 112,278 | 105,182 | 94,170 | 85,738 | 72,760 | Upgrade |
Allowance for Loan Losses | -2,368 | -2,638 | -2,896 | -2,846 | -2,641 | -2,364 | Upgrade |
Other Adjustments to Gross Loans | - | -335.74 | -206.19 | -144.69 | -163.5 | -280.67 | Upgrade |
Net Loans | 115,689 | 109,304 | 102,080 | 91,179 | 82,933 | 70,115 | Upgrade |
Property, Plant & Equipment | 2,654 | 2,371 | 2,158 | 2,105 | 1,925 | 1,896 | Upgrade |
Other Receivables | 1,791 | 1,609 | 2,836 | 741.45 | 517.52 | 1,438 | Upgrade |
Restricted Cash | 6,224 | 6,012 | 5,448 | 5,013 | 4,693 | 4,004 | Upgrade |
Other Current Assets | - | 245.61 | 189.38 | 135.72 | 88.1 | 95.06 | Upgrade |
Other Long-Term Assets | 1,191 | 1,640 | 1,420 | 706 | 433.97 | 715.99 | Upgrade |
Total Assets | 161,902 | 154,965 | 143,106 | 129,543 | 110,854 | 95,754 | Upgrade |
Accounts Payable | - | 4,963 | 4,899 | 4,957 | 2,115 | 2,168 | Upgrade |
Accrued Expenses | - | 717.79 | 739.85 | 641.65 | 531.08 | 578.56 | Upgrade |
Interest Bearing Deposits | 86,130 | 83,951 | 74,071 | 57,907 | 47,453 | 36,690 | Upgrade |
Non-Interest Bearing Deposits | 44,107 | 43,318 | 43,034 | 47,557 | 42,435 | 40,266 | Upgrade |
Total Deposits | 130,237 | 127,269 | 117,105 | 105,464 | 89,888 | 76,956 | Upgrade |
Short-Term Borrowings | - | 25.79 | 26.37 | 34.44 | - | - | Upgrade |
Long-Term Debt | 3,144 | 3,147 | 3,052 | 3,040 | 3,015 | 2,005 | Upgrade |
Long-Term Leases | - | 281.95 | 370.56 | 519.73 | 483.4 | 449.57 | Upgrade |
Other Long-Term Liabilities | 7,765 | 1,867 | 1,655 | 1,487 | 2,841 | 2,856 | Upgrade |
Total Liabilities | 141,146 | 138,271 | 127,848 | 116,144 | 98,874 | 85,013 | Upgrade |
Common Stock | 15,000 | 12,500 | 10,000 | 10,000 | 7,500 | 7,500 | Upgrade |
Retained Earnings | 3,719 | 4,753 | 5,554 | 3,680 | 1,592 | 2,404 | Upgrade |
Treasury Stock | -190.44 | -210.87 | -148.49 | -53.01 | -61.95 | -70.53 | Upgrade |
Comprehensive Income & Other | 2,228 | -349.03 | -147.18 | -228.1 | 2,950 | 907.41 | Upgrade |
Total Common Equity | 20,756 | 16,693 | 15,258 | 13,399 | 11,980 | 10,741 | Upgrade |
Shareholders' Equity | 20,756 | 16,693 | 15,258 | 13,399 | 11,980 | 10,741 | Upgrade |
Total Liabilities & Equity | 161,902 | 154,965 | 143,106 | 129,543 | 110,854 | 95,754 | Upgrade |
Total Debt | 3,144 | 3,455 | 3,449 | 3,595 | 3,499 | 2,454 | Upgrade |
Net Cash (Debt) | 3,596 | 6,419 | 4,508 | 6,358 | 654.85 | 1,259 | Upgrade |
Net Cash Growth | -13.90% | 42.39% | -29.10% | 870.96% | -47.98% | -69.17% | Upgrade |
Net Cash Per Share | 2.41 | 4.31 | 3.02 | 4.26 | 0.44 | 0.84 | Upgrade |
Filing Date Shares Outstanding | 1,502 | 1,490 | 1,490 | 1,488 | 1,500 | 1,500 | Upgrade |
Total Common Shares Outstanding | 1,502 | 1,490 | 1,490 | 1,488 | 1,500 | 1,500 | Upgrade |
Book Value Per Share | 13.82 | 11.20 | 10.24 | 9.00 | 7.99 | 7.16 | Upgrade |
Tangible Book Value | 20,756 | 16,693 | 15,258 | 13,399 | 11,980 | 10,741 | Upgrade |
Tangible Book Value Per Share | 13.82 | 11.20 | 10.24 | 9.00 | 7.99 | 7.16 | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.